-
—hindering early immunogenicity risk assessment during protein drug development. A deeper understanding of the mechanisms driving T-cell activation would represent a paradigm shift in biologics development
-
these therapeutics to the right organ with the right dose. Our research performance involves developing novel and innovative drug delivery technologies that can carry proteins, RNAs, or gene editors to the target
Searches related to protein
Enter an email to receive alerts for protein positions